In Episode 188 of EM Cases, Drs. Scott Weingart and Bourke Tillmann provide invaluable insights into managing hemoptysis, a condition marked by the expectoration of blood from the respiratory tract. The podcast emphasizes key principles and a comprehensive 5-step approach to effectively address this critical condition.
Key Principles:
Patients often confuse hemoptysis with upper airway or GI bleeding, emphasizing the need to differentiate hemoptysis from pseudohemoptysis.
Early diagnosis through chest CT with contrast is crucial for effective management.
Source control of bleeding, typically from bronchial arteries, is the ultimate goal and necessitates early involvement of interventional radiology, thoracic surgery, or respirology.
Patients should be positioned with the bleeding lung down in lateral decubitus to prevent contamination of the contralateral lung.
Hemorrhage control measures, including nebulized tranexamic acid (TXA), should be employed as a bridge to definitive treatment/source control.
5-Step Approach to Hemoptysis:
Differentiate hemoptysis from pseudohemoptysis: Patients are poor at identifying the source of bleeding, and distinguishing hemoptysis from alternative sources is challenging.
Determine if it's massive/life-threatening: Consider signs of respiratory distress, airway obstruction, abnormal gas exchange, and hemodynamic instability.
Early diagnosis guides management: Focus on critical time-sensitive diagnoses (tracheo-innominate fistula, aortobronchial fistula, pulmonary embolism) before considering the broader differential diagnosis.
Hemorrhage control measures prior to source control: Address bleeding as a bridge to source control; consider factors such as reversal of anticoagulants, nebulized/IV TXA, and blood product transfusions.
Definitive management and source control: Involve a multidisciplinary team for arterial embolization or other measures based on the underlying diagnosis.
Role of Investigations:
CT chest with contrast is prioritized for its higher diagnostic yield over bronchoscopy, especially in the arterial phase.
Bronchoscopy, while complementary to CT, should not replace it and is considered in intubated patients or when CT is not feasible.
Portable chest X-ray may be useful in minority cases for localizing bleeding side but is not a substitute for CT.
Role of TXA:
Limited evidence suggests benefits of inhaled/nebulized as well as IV TXA in hemoptysis.
Inhaled TXA is recommended for its physiological delivery to the lungs, especially for non-massive hemoptysis.
Airway Management in Massive Hemoptysis:
Delay intubation as long as possible due to potential destabilization from increased blood accumulation.
Consider endotracheal intubation via RSI and standard video laryngoscopy as the preferred method for securing the airway.
Conclusion:
The podcast provides a comprehensive guide to managing hemoptysis, emphasizing early diagnosis, effective source control, and a collaborative approach for optimal patient outcomes. Healthcare professionals are encouraged to stay updated on the latest evidence and guidelines for managing this critical condition.